JPH08503692A - 上皮小体ホルモン断片及びアナログ - Google Patents

上皮小体ホルモン断片及びアナログ

Info

Publication number
JPH08503692A
JPH08503692A JP6505568A JP50556894A JPH08503692A JP H08503692 A JPH08503692 A JP H08503692A JP 6505568 A JP6505568 A JP 6505568A JP 50556894 A JP50556894 A JP 50556894A JP H08503692 A JPH08503692 A JP H08503692A
Authority
JP
Japan
Prior art keywords
pth
parathyroid hormone
patient
human parathyroid
hormone fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP6505568A
Other languages
English (en)
Japanese (ja)
Inventor
アール． ヒリカー，サンドラ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JPH08503692A publication Critical patent/JPH08503692A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
JP6505568A 1992-08-05 1993-08-05 上皮小体ホルモン断片及びアナログ Pending JPH08503692A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US92607092A 1992-08-05 1992-08-05
US07/926,070 1992-08-05
PCT/US1993/007375 WO1994003201A1 (fr) 1992-08-05 1993-08-05 Fragments et analogues d'hormone parathyroidienne

Publications (1)

Publication Number Publication Date
JPH08503692A true JPH08503692A (ja) 1996-04-23

Family

ID=25452700

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6505568A Pending JPH08503692A (ja) 1992-08-05 1993-08-05 上皮小体ホルモン断片及びアナログ

Country Status (4)

Country Link
EP (1) EP0656784A4 (fr)
JP (1) JPH08503692A (fr)
CA (1) CA2141588A1 (fr)
WO (1) WO1994003201A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5814603A (en) * 1992-06-12 1998-09-29 Affymax Technologies N.V. Compounds with PTH activity
DE4434551A1 (de) * 1994-09-28 1996-04-04 Forssmann Wolf Georg Prof Dr D Peptide aus der Sequenz des hPTH (1-37)
AUPP794898A0 (en) * 1998-12-24 1999-01-28 Garvan Institute Of Medical Research Transgenic animal
US7820393B2 (en) 1999-01-14 2010-10-26 Scantibodies Laboratory, Inc. Methods, kits and antibodies for detecting parathyroid hormone
US6689566B1 (en) 1999-01-14 2004-02-10 Scantibodies Laboratory, Inc. Methods, kits, and antibodies for detecting parathyroid hormone
US6923968B2 (en) 2000-08-10 2005-08-02 Scantibodies Laboratory, Inc. Cyclase inhibiting parathyroid hormone antagonists or modulators and osteoporosis
WO2004028444A2 (fr) 1999-06-02 2004-04-08 Scantibodies Laboratory, Inc. Antagonistes de la parathormone et utilisations de ceux-ci
US7056655B2 (en) 2001-11-02 2006-06-06 Scantibodies Laboratory, Inc. Methods for monitoring and guiding therapeutic suppression of parathyroid hormone in renal patients having secondary hyperparathyroidism
US6524788B1 (en) 2001-11-02 2003-02-25 Thomas L. Cantor Methods for monitoring and guiding therapeutic suppression of parathyroid hormone in renal patients having secondary hyperparathyroidism
AU2003207512B2 (en) 2002-01-10 2008-06-12 Osteotrophin Llc Treatment of bone disorders with skeletal anabolic drugs
AU2006315132A1 (en) 2005-11-10 2007-05-24 Board Of Control Of Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
JP2013512688A (ja) 2009-12-07 2013-04-18 ミシガン テクノロジカル ユニバーシティ クロクマの副甲状腺ホルモン及びクロクマの副甲状腺ホルモンを使用する方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4086196A (en) * 1975-03-28 1978-04-25 Armour Pharmaceutical Company Parathyroid hormone
US4968669A (en) * 1988-05-09 1990-11-06 Merck & Co., Inc. Parathyroid hormone antagonists
DE4203040A1 (de) * 1992-02-04 1993-08-05 Boehringer Mannheim Gmbh Neue parathormonfragmente, deren herstellung und diese enthaltende arzneimittel

Also Published As

Publication number Publication date
CA2141588A1 (fr) 1994-02-17
EP0656784A1 (fr) 1995-06-14
WO1994003201A1 (fr) 1994-02-17
EP0656784A4 (fr) 1997-06-04

Similar Documents

Publication Publication Date Title
US6472505B1 (en) Peptide parathyroid hormone analogs
JP4620309B2 (ja) 骨粗鬆症治療用副甲状腺ホルモン類似体
US5939386A (en) Chimeric fatty body-pro-GRF (1-29) analogs with increased biological potency
US7504107B2 (en) Methods of priming the immunogenic activity of vaccines useful for eliciting a protective immune response
JP2557779B2 (ja) ２成分型骨粗鬆症用薬剤
US5470828A (en) Peptide analogs of insulin-like growth factor II
JPH0674279B2 (ja) 成長ホルモン放出性因子類似体及びその製造方法
HUP0004560A2 (hu) Törést gyógyító PTHrP analógok
JPH08503692A (ja) 上皮小体ホルモン断片及びアナログ
RU2203286C2 (ru) Аналоги паратиреоидного гормона для лечения остеопороза
IL98638A (en) Analogs of the factor that releases human growth hormone, their preparation and pharmaceutical preparations that contain them
JPH10512280A (ja) ＰＴＨおよびＰＴＨｒＰの環式同族体
JP6375089B2 (ja) 強力なアゴニスト作用を有する新規なｇｈ−ｒｈ類似体
DE69838647D1 (de) Behandlung von fettleibigkeit
JP2002530432A (ja) Ｇｈ−ｒｈ阻害ｉｇｆ−ｉおよびｉｉの拮抗類似体
EP0687270B1 (fr) Oligopeptides de croissance osteogene et compositions pharmaceutiques les contenant
EP0188214A2 (fr) Peptides libérant l'hormone de croissance et méthodes de traitement de mammifères avec ces peptides
US7034050B2 (en) Pseudopeptides growth hormone secretagogues
RU2503684C2 (ru) Иммуномодулирующие олигопептиды
CN1030255C (zh) 环形生长激素释放因子(grf)类似物的制备方法
JPH07316195A (ja) 新規なＰＴＨｒＰ関連ペプチド及びその用途
RU2119800C1 (ru) Аналог пептида фактора гормона роста (фгр), способ стимулирования секреции гормона роста и композиция для стимулирования секреции
CA1340077C (fr) Derives ¬ser 17, leu 18| grf
Shi et al. Nasal administration of a novel recombinant human parathyroid hormone (1–34) analog for the treatment of osteoporosis of ovariectomized rats
JP2008501641A (ja) 成長ホルモン分泌促進物質であるプソイドペプチド類